Search

everythinglearnresearchcommunity

for

Search:↓

An elderly Chinese man lost all his hair after taking a new heart medication.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

OCT can effectively screen and diagnose various medical conditions non-invasively.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

A woman's complete hair loss condition improved after recovering from COVID-19.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Exosomes from fat-derived stem cells can potentially improve hair growth and could be a new treatment for immune-related hair loss.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Light therapy is effective and safe for treating skin color disorders like vitiligo and dark spots.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Non-drug therapies show promise for hair regrowth but need more research.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

The document concludes that more research is needed to find effective treatments for Lichen planopilaris and Frontal fibrosing alopecia.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.

Platelet-rich plasma can increase hair density and may help treat some skin conditions, but it's costly, not FDA-approved, and needs more research.

RF-based therapies might help treat hair loss.

New small molecule drugs could help treat hair loss.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.